Skip to main content
Log in

Mitochondrial Dysfunction Induced by Statin Contributes to Endothelial Dysfunction in Patients with Coronary Artery Disease

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Despite the use of statin therapy, a significant proportion of patients with coronary artery disease (CAD) still develop cardiovascular events. We hypothesized that development of mitochondrial dysfunction (MD) after statin therapy might be linked to endothelial dysfunction and thus limiting its beneficial effects. We studied the effect of MD on endothelial function in 119 patients with CAD on long-term statins (>1 year). Brachial artery flow-mediated dilation (FMD) was assessed by high-resolution ultrasonography and blood levels of lactate, pyruvate, fasting glucose, and lipids were measured. MD (defined by a lactate/pyruvate ratio >75th percentile of the age- and sex-matched normal controls, i.e., ≥18) was observed in 43/119(36%) patients. There were no significant differences in age, gender, and clinical characteristics between patients with or without MD (all P > 0.05). Patients with MD received higher dose of statin (23.5 ± 19.3 vs. 17.1 ± 10.5 mg simvastatin-equivalent dose, P = 0.05) and had lower FMD (2.69 ± 2.94 vs. 4.33 ± 2.80%, P = 0.003) than those without MD. Multivariate analysis showed that statin dosage was independently associated with MD (OR:1.03, P = 0.03), and MD significantly predicted an absolute 1.36% decrease in FMD (P = 0.01). In conclusion, a significant proportion of patients with CAD on statin developed MD, which was associated with high-dose statin and with impaired FMD, suggesting that increased statin dosage may induce MD and contribute to endothelial dysfunction in patients with CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. LaRosa, J. C., He, J., & Vupputuri, S. (1999). Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA, 282, 2340–2346.

    Article  CAS  PubMed  Google Scholar 

  2. Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352, 29–38.

    Article  CAS  PubMed  Google Scholar 

  3. Langsjoen, P. H., & Langsjoen, A. M. (2003). The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. Biofactors, 18, 101–111.

    Article  CAS  PubMed  Google Scholar 

  4. Thompson, P. D., Clarkson, P., & Karas, R. H. (2003). Statin-associated myopathy. JAMA, 289, 1681–1690.

    Article  CAS  PubMed  Google Scholar 

  5. Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., et al. (2002). Statin-associated myopathy with normal creatine kinase levels. Annals of Internal Medicine, 137, 581–585.

    PubMed  Google Scholar 

  6. Chariot, P., Monnet, I., Mouchet, M., Rohr, M., Lefaucheur, J. P., Dubreuil-Lemaire, M. L., et al. (1994). Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis and Rheumatism, 37, 583–586.

    Article  CAS  PubMed  Google Scholar 

  7. Munnich, A., Rotig, A., Chretien, D., Saudubray, J. M., Cormier, V., & Rustin, P. (1996). Clinical presentations and laboratory investigations in respiratory chain deficiency. European Journal of Pediatrics, 155, 262–274.

    Article  CAS  PubMed  Google Scholar 

  8. De Pinieux, G., Chariot, P., Ammi-Said, M., Louarn, F., Lejonc, J. L., Astier, A., et al. (1996). Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. British Journal of Clinical Pharmacology, 42, 333–337.

    Article  CAS  PubMed  Google Scholar 

  9. Heart Protection Study Collaborative Group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360, 7–22.

    Article  Google Scholar 

  10. Madamanchi, N. R., & Runge, M. S. (2007). Mitochondrial dysfunction in atherosclerosis. Circulation Research, 100, 460–473.

    Article  CAS  PubMed  Google Scholar 

  11. Puddu, P., Puddu, G. M., Galletti, L., Cravero, E., & Muscari, A. (2005). Mitochondrial dysfunction as an initiating event in atherogenesis: A plausible hypothesis. Cardiology, 103, 137–141.

    Article  CAS  PubMed  Google Scholar 

  12. Lerman, A., & Zeiher, A. M. (2005). Endothelial function: Cardiac events. Circulation, 111, 363–368.

    Article  PubMed  Google Scholar 

  13. Chan, Y. H., Lau, K. K., Yiu, K. H., Li, S. W., Chan, H. T., Tam, S., et al. (2007). Isoflavone intake in persons at high risk of cardiovascular events: Implications for vascular endothelial function and the carotid atherosclerotic burden. American Journal of Clinical Nutrition, 86, 938–945.

    CAS  PubMed  Google Scholar 

  14. Lau, K. K., Chan, Y. H., Yiu, K. H., Li, S. W., Tam, S., Lau, C. P., et al. (2007). Burden of carotid atherosclerosis in patients with stroke: Relationships with circulating endothelial progenitor cells and hypertension. Journal of Human Hypertension, 21, 445–451.

    PubMed  Google Scholar 

  15. Scranton, R. E., Young, M., Lawler, E., Solomon, D., Gagnon, D., & Gaziano, J. M. (2005). Statin use and fracture risk: Study of a US veterans population. Archives of Internal Medicine, 165, 2007–2012.

    Article  PubMed  Google Scholar 

  16. Tan, K. C., Wat, N. M., Tam, S. C., Janus, E. D., Lam, T. H., & Lam, K. S. (2003). C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care, 26, 2323–2328.

    Article  CAS  PubMed  Google Scholar 

  17. Debray, F. G., Mitchell, G. A., Allard, P., Robinson, B. H., Hanley, J. A., & Lambert, M. (2007). Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. Clinical Chemistry, 53, 916–921.

    Article  CAS  PubMed  Google Scholar 

  18. Ip, M. S., Tse, H. F., Lam, B., Tsang, K. W., & Lam, W. K. (2004). Endothelial function in obstructive sleep apnea and response to treatment. American Journal of Respiratory and Critical Care Medicine, 169, 348–353.

    Article  PubMed  Google Scholar 

  19. Lamperti, C., Naini, A. B., Lucchini, V., Prelle, A., Bresolin, N., Moggio, M., et al. (2005). Muscle coenzyme Q10 level in statin-related myopathy. Archives of Neurology, 62, 1709–1712.

    Article  PubMed  Google Scholar 

  20. Gutierrez, J., Ballinger, S. W., Darley-Usmar, V. M., & Landar, A. (2006). Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circulation Research, 99, 924–932.

    Article  CAS  PubMed  Google Scholar 

  21. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404, 787–790.

    Article  CAS  PubMed  Google Scholar 

  22. Knight-Lozano, C. A., Young, C. G., Burow, D. L., Hu, Z. Y., Uyeminami, D., Pinkerton, K. E., et al. (2002). Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation, 105, 849–854.

    Article  CAS  PubMed  Google Scholar 

  23. Kavanagh, T., Mertens, D. J., Hamm, L. F., Beyene, J., Kennedy, J., Corey, P., et al. (2003). Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. Journal of the American College of Cardiology, 42, 2139–2143.

    Article  PubMed  Google Scholar 

  24. Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002). Exercise capacity and mortality among men referred for exercise testing. New England Journal of Medicine, 346, 793–801.

    Article  PubMed  Google Scholar 

  25. Csiszar, A., Labinskyy, N., Orosz, Z., & Ungvari, Z. (2006). Altered mitochondrial energy metabolism may play a role in vascular aging. Medical Hypotheses, 67, 904–908.

    Article  CAS  PubMed  Google Scholar 

  26. Lee, J. Y., Jung, G. Y., Heo, H. J., Yun, M. R., Park, J. Y., Bae, S. S., et al. (2006). 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicology Letters, 166, 212–221.

    Article  CAS  PubMed  Google Scholar 

  27. Kinscherf, R., Deigner, H. P., Usinger, C., Pill, J., Wagner, M., Kamencic, H., et al. (1997). Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J, 11, 1317–1328.

    CAS  PubMed  Google Scholar 

  28. Van Etten, R. W., de Koning, E. J., Honing, M. L., Stroes, E. S., Gaillard, C. A., & Rabelink, T. J. (2002). Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 799–804.

    Article  PubMed  Google Scholar 

  29. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., et al. (2009). Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet, 373, 1175–1182.

    Article  CAS  PubMed  Google Scholar 

  30. Wenzel, P., Schuhmacher, S., Kienhofer, J., Muller, J., Hortmann, M., Oelze, M., et al. (2008). Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovascular Research, 80, 280–289.

    Article  CAS  PubMed  Google Scholar 

  31. Yufu, K., Takahashi, N., Hara, M., Saikawa, T., & Yoshimatsu, H. (2007). Measurement of the brachial-ankle pulse wave velocity and flow-mediated dilatation in young, healthy smokers. Hypertension Research, 30, 607–612.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the CRCG Small Project Funding of University of Hong Kong (Project No. 200907176063) and Sun Chieh Yeh Heart Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hung-Fat Tse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dai, YL., Luk, TH., Siu, CW. et al. Mitochondrial Dysfunction Induced by Statin Contributes to Endothelial Dysfunction in Patients with Coronary Artery Disease. Cardiovasc Toxicol 10, 130–138 (2010). https://doi.org/10.1007/s12012-010-9071-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-010-9071-1

Keywords

Navigation